Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2018-06-10
2018-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Uncontrolled Hypertension Management Among Jordanian Adults
NCT06156631
DCP3 Based Multi-component Intervention for Hypertension Management and Control
NCT04336631
Effects of Life Style Intervention Manual in Pre Hypertensive Sedentary Population
NCT04841902
Educational Intervention for Hypertension Management
NCT05038774
Assessing the Feasibility of Multimedia Interventions to Reduce Blood Pressure in Marginalized Hypertensive Communities of Karachi, Pakistan
NCT07131176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Design: Randomized controlled trial Place and Duration of Study: Punjab Institute of Cardiology (PIC) Lahore. From June 2018 to Oct 2018.
Methodology: Seventy volunteers aged 20-60 years attending regularly outpatient department at Punjab institute of cardiology Lahore, with systolic \> 130 mm hg, diastolic \> 80 mm hg were selected and assigned into 2 groups, i.e. Intervention and control, by simple random lottery method. For twelve weeks, only intervention group were given DASH education. Both groups were checked for DASH knowledge, attitude, and systolic diastolic blood pressure, before and after education session. Pre-tested questionnaire was used for demographic, attitude and knowledge data collection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
For twelve weeks, only intervention group were given DASH education
DASH Education
DASH health education about general knowledge of DASH diet Plan and lifestyle modification
Controlled
Controlled group not received DASH education
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DASH Education
DASH health education about general knowledge of DASH diet Plan and lifestyle modification
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* systolic \> 130 mm hg
* diastolic \> 80 mm hg.
Exclusion Criteria
* patient diagnosed with secondary hypertension
* any mental and physical ailment that may interfere the intervention like deafness and blindness.
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allama Iqbal Open University Islamabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Naiza Yousef
Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zaheer Ahmad, PhD
Role: PRINCIPAL_INVESTIGATOR
Shalamar Institute of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nazia
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIHS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.